FDA Laboratory Developed Test Oversight: What Stakeholders Need to Know About Proposed Overhaul October 10, 2023
DEA Extends Telemedicine Flexibilities for Prescribing of Controlled Medications: Second Time is the Charm October 9, 2023
DTC Promotional Labeling and Advertisements: Quantitative Efficacy Wins Over FDA in Final Guidance on Presenting Risk Information September 11, 2023
DEA: Potential New Telemedicine Special Registration for Controlled Substances Prescribing to be Discussed in Special Listening Sessions August 8, 2023